St. Jude Children's Research Hospital Celebrates 50 Years2/4/2012 1:00:00 PM
Evergreen Neurologist Co-Authors New Study Linking Coffee, Genetics and Parkinson's Disease Prevention2/3/2012 5:45:00 PM
Questcor Announces Preliminary Fourth Quarter and Full Year 2011 Net Sales and Operating Income2/3/2012 2:15:00 PM
Aeterna Zentaris Reports Updated Phase 1 Trial Results for AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer at ASCO GCS Meeting2/3/2012 12:37:00 PM
New Study of Primary Liver Cancer Seeks to Enroll 400 French Patients2/3/2012 7:00:00 AM
Spherix Announces Registered Direct Offering of $1.15 Million2/2/2012 7:46:00 PM
Prime Healthcare Withdraws Bid for Christ Hospital2/2/2012 7:03:00 PM
The Michael J. Fox Foundation Pilots Partnering Program Between Awardees and Industry2/2/2012 5:00:00 PM
Bedford Laboratories™ Issues a Voluntary Nationwide Patient Level Recall of Acetylcysteine Solution, USP, Lot 18770932/2/2012 4:31:00 PM
Society of Gynecologic Oncology to Host 43rd Annual Meeting on Women's Cancer®2/2/2012 4:00:00 PM
Partner With Your Pharmacist to Monitor Heart Health2/2/2012 3:00:00 PM
International Phase I Trial Results of Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) Show All Pharmacokinetic Parameters Significantly Improved in Patients With Severe Hemophilia B2/2/2012 2:45:00 PM
BioParadox Announces Partnership with Fogarty Institute for Innovation2/2/2012 1:30:00 PM
Ronnie Andrews Joins Life Technologies as President, Medical Sciences2/2/2012 1:00:00 PM
Phase 1 Study of OGX-427 Presented at the ASCO 2012 Genitourinary Cancers Symposium Shows Early Evidence of Activity in Bladder Cancer2/2/2012 1:00:00 PM
Clinical Data on OGX-427 Presented at the ASCO 2012 Genitourinary Cancers Symposium Provide Ongoing Evidence of Hsp27 as a Potential Therapeutic Target in Advanced Prostate Cancer2/2/2012 1:00:00 PM
Insero Health Closes Initial Round of Financing and Signs Exclusive Licenses With Harvard and Yale2/2/2012 12:30:00 PM
EUSA Pharma Acquires Development and Commercialization Rights to ASPAREC® for Treatment of Acute Lymphoblastic Leukemia from Alizé Pharma2/2/2012 9:30:00 AM
ThromboGenics Announces That the FDA Intends to Grant Ocriplasmin Priority Review2/2/2012 6:30:00 AM
IntraOp Medical wins Patent Defense Suit Protecting Their Intellectual Property2/1/2012 11:21:00 PM
Experts here are available to answer all your questions!